Nelson Sun Purchases 10,000 Shares of Aardvark Therapeutics, Inc. (NASDAQ:AARD) Stock

Aardvark Therapeutics, Inc. (NASDAQ:AARD) CFO Nelson Sun acquired 10,000 shares of the stock in a transaction on Friday, February 14th. The stock was acquired at an average cost of $16.00 per share, for a total transaction of $160,000.00. Following the acquisition, the chief financial officer now directly owns 99,484 shares in the company, valued at $1,591,744. This represents a 11.18 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Aardvark Therapeutics Price Performance

Shares of AARD traded up $1.34 during mid-day trading on Wednesday, hitting $14.90. The company’s stock had a trading volume of 166,154 shares, compared to its average volume of 176,008. Aardvark Therapeutics, Inc. has a 1-year low of $11.55 and a 1-year high of $16.48.

About Aardvark Therapeutics

We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. We target biological pathways associated with alleviating hunger that we believe have the potential to deliver transformative outcomes for patients.